- Home
- SKWD vs DYN Comparison
SKWD vs DYN Comparison
Compare SKWD & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKWD
- DYN
- Stock Information
- Founded
- SKWD 2007
- DYN 1984
- Country
- SKWD United States
- DYN United States
- Employees
- SKWD N/A
- DYN N/A
- Industry
- SKWD Property-Casualty Insurers
- DYN Medicinal Chemicals and Botanical Products
- Sector
- SKWD Finance
- DYN Health Care
- Exchange
- SKWD Nasdaq
- DYN Nasdaq
- Market Cap
- SKWD 2.3B
- DYN 1.9B
- IPO Year
- SKWD 2023
- DYN 2020
- Fundamental
- Price
- SKWD $50.23
- DYN $14.22
- Analyst Decision
- SKWD Buy
- DYN Strong Buy
- Analyst Count
- SKWD 11
- DYN 14
- Target Price
- SKWD $63.78
- DYN $34.93
- AVG Volume (30 Days)
- SKWD 383.2K
- DYN 2.4M
- Earning Date
- SKWD 10-28-2025
- DYN 07-28-2025
- Dividend Yield
- SKWD N/A
- DYN N/A
- EPS Growth
- SKWD 6.84
- DYN N/A
- EPS
- SKWD 3.16
- DYN N/A
- Revenue
- SKWD $1,253,720,000.00
- DYN N/A
- Revenue This Year
- SKWD $17.46
- DYN N/A
- Revenue Next Year
- SKWD $11.77
- DYN N/A
- P/E Ratio
- SKWD $15.90
- DYN N/A
- Revenue Growth
- SKWD 21.67
- DYN N/A
- 52 Week Low
- SKWD $37.79
- DYN $6.36
- 52 Week High
- SKWD $65.05
- DYN $37.08
- Technical
- Relative Strength Index (RSI)
- SKWD 52.02
- DYN 73.48
- Support Level
- SKWD $48.01
- DYN $13.03
- Resistance Level
- SKWD $54.00
- DYN $13.85
- Average True Range (ATR)
- SKWD 1.25
- DYN 0.64
- MACD
- SKWD 0.41
- DYN 0.04
- Stochastic Oscillator
- SKWD 43.14
- DYN 95.55
About SKWD Skyward Specialty Insurance Group Inc.
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.